208 related articles for article (PubMed ID: 25664811)
1. New insights into protease-activated receptor 4 signaling pathways in the pathogenesis of inflammation and neuropathic pain: a literature review.
Bao Y; Gao Y; Yang L; Kong X; Zheng H; Hou W; Hua B
Channels (Austin); 2015; 9(1):5-13. PubMed ID: 25664811
[TBL] [Abstract][Full Text] [Related]
2. Protease-activated receptor 2 signalling pathways: a role in pain processing.
Bao Y; Hou W; Hua B
Expert Opin Ther Targets; 2014 Jan; 18(1):15-27. PubMed ID: 24147628
[TBL] [Abstract][Full Text] [Related]
3. Protease-activated receptor 4 activation increases the expression of calcitonin gene-related peptide mRNA and protein in dorsal root ganglion neurons.
Wang Z; Chen D; Zhang Z; Zhang R; An S; Yu L
J Neurosci Res; 2013 Dec; 91(12):1551-62. PubMed ID: 24105611
[TBL] [Abstract][Full Text] [Related]
4. Protease-activated receptors in cardiovascular diseases.
Leger AJ; Covic L; Kuliopulos A
Circulation; 2006 Sep; 114(10):1070-7. PubMed ID: 16952995
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor 4 uses anionic residues to interact with alpha-thrombin in the absence or presence of protease-activated receptor 1.
Nieman MT
Biochemistry; 2008 Dec; 47(50):13279-86. PubMed ID: 19053259
[TBL] [Abstract][Full Text] [Related]
6. Complement protease MASP-1 activates human endothelial cells: PAR4 activation is a link between complement and endothelial function.
Megyeri M; Makó V; Beinrohr L; Doleschall Z; Prohászka Z; Cervenak L; Závodszky P; Gál P
J Immunol; 2009 Sep; 183(5):3409-16. PubMed ID: 19667088
[TBL] [Abstract][Full Text] [Related]
7. Understanding the role of mitochondria in the pathogenesis of chronic pain.
Sui BD; Xu TQ; Liu JW; Wei W; Zheng CX; Guo BL; Wang YY; Yang YL
Postgrad Med J; 2013 Dec; 89(1058):709-14. PubMed ID: 24151337
[TBL] [Abstract][Full Text] [Related]
8. PARs in the inflammation-cancer transformation of CRC.
Lv J; Liu J; Chao G; Zhang S
Clin Transl Oncol; 2023 May; 25(5):1242-1251. PubMed ID: 36547764
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation via PAR4 is involved in the initiation of thrombin generation and in clot elasticity development.
Vretenbrant K; Ramström S; Bjerke M; Lindahl TL
Thromb Haemost; 2007 Mar; 97(3):417-24. PubMed ID: 17334509
[TBL] [Abstract][Full Text] [Related]
10. PAR1 antagonists inhibit thrombin-induced platelet activation whilst leaving the PAR4-mediated response intact.
Judge HM; Jennings LK; Moliterno DJ; Hord E; Ecob R; Tricoci P; Rorick T; Kotha J; Storey RF
Platelets; 2015; 26(3):236-42. PubMed ID: 24750101
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets.
Fälker K; Haglund L; Gunnarsson P; Nylander M; Lindahl TL; Grenegård M
Biochem J; 2011 Jun; 436(2):469-80. PubMed ID: 21391917
[TBL] [Abstract][Full Text] [Related]
12. Pepducin-based intervention of thrombin-receptor signaling and systemic platelet activation.
Covic L; Misra M; Badar J; Singh C; Kuliopulos A
Nat Med; 2002 Oct; 8(10):1161-5. PubMed ID: 12357249
[TBL] [Abstract][Full Text] [Related]
13. Chemokines and cytokines in neuroinflammation leading to neuropathic pain.
Kiguchi N; Kobayashi Y; Kishioka S
Curr Opin Pharmacol; 2012 Feb; 12(1):55-61. PubMed ID: 22019566
[TBL] [Abstract][Full Text] [Related]
14. Proteinase-activated receptors: novel signals for peripheral nerves.
Vergnolle N; Ferazzini M; D'Andrea MR; Buddenkotte J; Steinhoff M
Trends Neurosci; 2003 Sep; 26(9):496-500. PubMed ID: 12948661
[TBL] [Abstract][Full Text] [Related]
15. Thrombin signaling in the brain: the role of protease-activated receptors.
Wang H; Reiser G
Biol Chem; 2003 Feb; 384(2):193-202. PubMed ID: 12675511
[TBL] [Abstract][Full Text] [Related]
16. Neutrophil proteases can inactivate human PAR3 and abolish the co-receptor function of PAR3 on murine platelets.
Cumashi A; Ansuini H; Celli N; De Blasi A; O'Brien PJ; Brass LF; Molino M
Thromb Haemost; 2001 Mar; 85(3):533-8. PubMed ID: 11307827
[TBL] [Abstract][Full Text] [Related]
17. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
Bilodeau ML; Hamm HE
J Pharmacol Exp Ther; 2007 Aug; 322(2):778-88. PubMed ID: 17525299
[TBL] [Abstract][Full Text] [Related]
18. Chemokine mediated neuron-glia communication and aberrant signalling in neuropathic pain states.
Old EA; Malcangio M
Curr Opin Pharmacol; 2012 Feb; 12(1):67-73. PubMed ID: 22056024
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor signaling in injured nerves underlies peripheral sensitization in neuropathic pain.
Kiguchi N; Kobayashi Y; Kadowaki Y; Fukazawa Y; Saika F; Kishioka S
J Neurochem; 2014 Apr; 129(1):169-78. PubMed ID: 24304382
[TBL] [Abstract][Full Text] [Related]
20. PAR3 is a cofactor for PAR4 activation by thrombin.
Nakanishi-Matsui M; Zheng YW; Sulciner DJ; Weiss EJ; Ludeman MJ; Coughlin SR
Nature; 2000 Apr; 404(6778):609-13. PubMed ID: 10766244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
